Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.21% |
| 2 | Technology | 11.19% |
| 3 | Healthcare | 7.18% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Financials | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Rayonier
RYN
$6.04B
| $1.39M | ﹤0.01% |
52,023
-323,140
| -86% | -$8.24M |
|
|
FOLD
3452
CALL
DELISTED
Amicus Therapeutics
FOLD
| $1.39M | ﹤0.01% |
+60,000
| New | +$1.23M |
|
3453
Huntington Ingalls Industries
HII
$11.5B
| $1.39M | ﹤0.01% |
8,125
-50,664
| -86% | -$8.05M |
|
3454
Badger Meter
BMI
$3.95B
| $1.38M | ﹤0.01% |
14,716
+909
| +7% | +$72.6K |
|
3455
Akamai
AKAM
$15.5B
| $1.38M | ﹤0.01% |
13,122
+5,619
| +75% | +$588K |
|
3456
CALL
Uber
UBER
$161B
| $1.38M | ﹤0.01% |
27,000
-141,000
| -84% | -$6.32M |
|
3457
CALL
Universal Health Services
UHS
$10.1B
| $1.38M | ﹤0.01% |
10,000
| – | – |
|
3458
PUT
Aldeyra Therapeutics
ALDX
$90.5M
| $1.37M | ﹤0.01% |
+200,000
| New | +$1.4M |
|
3459
Axos Financial
AX
$5.54B
| $1.37M | ﹤0.01% |
36,501
+2,641
| +8% | +$83.5K |
|
|
NBA.U
3460
DELISTED
New Beginnings Acquisition Corp. Units,eachconsistingofoneshareofcommon stock andoneredeema
NBA.U
| $1.37M | ﹤0.01% |
+125,000
| New | +$1.3M |
|
3461
Stepan Co
SCL
$1.42B
| $1.37M | ﹤0.01% |
11,457
+6,004
| +110% | +$707K |
|
|
SYNH
3462
PUT
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.36M | ﹤0.01% |
20,000
| – | – |
|
|
SIEN
3463
CALL
DELISTED
Sientra, Inc.
SIEN
| $1.36M | ﹤0.01% |
+35,000
| New | +$1.57M |
|
3464
Nabors Industries
NBR
$1.4B
| $1.36M | ﹤0.01% |
23,339
-27,577
| -54% | -$1.22M |
|
3465
State Street SPDR S&P Insurance ETF
KIE
$711M
| $1.36M | ﹤0.01% |
+40,442
| New | +$1.28M |
|
3466
Banco Bilbao Vizcaya Argentaria
BBVA
$160B
| $1.35M | ﹤0.01% |
274,248
-65,643
| -19% | -$252K |
|
|
QUOT
3467
DELISTED
Quotient Technology Inc
QUOT
| $1.35M | ﹤0.01% |
143,626
-333,618
| -70% | -$2.8M |
|
3468
Aclaris Therapeutics
ACRS
$885M
| $1.35M | ﹤0.01% |
208,926
-72,872
| -26% | -$307K |
|
3469
CALL
Cognizant
CTSH
$29.1B
| $1.35M | ﹤0.01% |
16,500
+8,800
| +114% | +$670K |
|
3470
CALL
MillerKnoll
MLKN
$1.58B
| $1.35M | ﹤0.01% |
+40,000
| New | +$1.39M |
|
3471
Telos
TLS
$354M
| $1.35M | ﹤0.01% |
+41,000
| New | +$978K |
|
3472
Lattice Semiconductor
LSCC
$16.3B
| $1.35M | ﹤0.01% |
+29,404
| New | +$1.14M |
|
|
MRSH
3473
CALL
Marsh
MRSH
$92.4B
| $1.35M | ﹤0.01% |
11,500
+3,600
| +46% | +$409K |
|
3474
Hyliion Holdings
HYLN
$632M
| $1.34M | ﹤0.01% |
81,340
+58,340
| +254% | +$1.33M |
|
3475
Arcturus Therapeutics
ARCT
$421M
| $1.34M | ﹤0.01% |
+30,865
| New | +$2.09M |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $25B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.